Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival
Стратификация риска при хронической тромбоэмболической легочной гипертензии прогнозирует выживаемость
2020-06-26
SCID: 54.1/ekfwxgjk
Discuss with AI
ESC/ERS risk assessmentchronic thromboembolic pulmonary hypertensionpulmonary endarterectomyrisk stratificationsurvival prediction
Figures from the paper
Abstract (AI)
Objectives To investigate if the pulmonary arterial hypertension (PAH) risk assessment tool presented in the 2015 ESC/ERS guidelines is valid for patients with chronic thromboembolic pulmonary hypertension (CTEPH) when taking pulmonary endarterectomy (PEA) into account. Design. Incident CTEPH patients registered in the Swedish PAH Registry (SPAHR) between 2008 and 2016 were included. Risk stratification performed at baseline and follow-up classified the patients as low-, intermediate-, or high-risk using the proposed ESC/ERS risk algorithm. Results. There were 250 CTEPH patients with median age (interquartile range) 70 (14) years, and 53% were male. Thirty-two percent underwent PEA within 5 (6) months. In a multivariable model adjusting for age, sex, and pharmacological treatment, patients with intermediate-risk or high-risk profiles at baseline displayed an increased mortality risk (Hazard Ratio [95% confidence interval]: 1.64 [0.69–3.90] and 5.39 [2.13–13.59], respectively) compared to those with a low-risk profile, whereas PEA was associated with better survival (0.38 [0.18–0.82]). Similar impact of risk profile and PEA was seen at follow-up. Conclusion. The ESC/ERS risk assessment tool identifies CTEPH patients with reduced survival. Furthermore, PEA improves survival markedly independently of risk group and age. Take home message: The ESC/ERS risk stratification for PAH predicts survival also in CTEPH patients, even when taking PEA into account.
Key Findings
1
At baseline, high-risk patients had substantially greater mortality than low-risk patients (HR 5.39, 95% CI 2.13–13.59), while intermediate-risk patients showed a nonsignificant increase (HR 1.64, 95% CI 0.69–3.90).
2
Pulmonary endarterectomy improved survival independently of baseline risk group and age.
3
Pulmonary endarterectomy was associated with markedly better survival (HR 0.38, 95% CI 0.18–0.82) after adjustment for age, sex, and pharmacological treatment.
4
Risk profile and pulmonary endarterectomy showed similar associations with survival at follow-up, indicating prognostic value over time.
5
The 2015 ESC/ERS PAH risk assessment tool effectively predicts survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH).
Research Object
Patients with chronic thromboembolic pulmonary hypertension (CTEPH), including those undergoing pulmonary endarterectomy (PEA)
Research Subject
The association of ESC/ERS risk profiles and pulmonary endarterectomy with survival
Publication Details
Publication Date
2020-06-26
Journal
Publisher
ISSN
Cited by
28
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension2015
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model2017
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension2019